{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:52:01Z","timestamp":1791409921197,"version":"4.3.3"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110309","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:36:33Z","timestamp":1785368193000},"page":"110309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of novel H3R antagonists with potent antiseizure activity and favorable pharmacokinetics via scaffold-hopping from pitolisant to rigid 4-phenylindoles"],"prefix":"10.1016","volume":"181","author":[{"given":"Ying","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuhong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingna","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruokun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10172","key":"10.1016\/j.bioorg.2026.110309_bb0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110309_bb0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bioorg.2026.110309_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocn.2025.111312","article-title":"Predictors of drug-resistant epilepsy among adult patients with epilepsy in tertiary referral hospital in Egypt","volume":"137","author":"El Serafy","year":"2025","journal-title":"J. Clin. Neurosci."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110309_bb0020","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70407","article-title":"The medical burden of drug-resistant epilepsy in an outpatient clinic of a tertiary hospital: a prospective study based on real-world evidence","volume":"32","author":"Gr\u00e1valos","year":"2025","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110309_bb0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12883-025-04149-w","article-title":"Drug-resistant epilepsy in Saudi Arabia: prevalence, predictive factors, and treatment outcomes","volume":"25","author":"Alghamdi","year":"2025","journal-title":"BMC Neurol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110309_bb0030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110309_bb0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00019052-200304000-00008","article-title":"The epidemiology of epilepsy revisited","volume":"16","author":"Sander","year":"2003","journal-title":"Curr. Opin. Neurol."},{"issue":"9\u201310","key":"10.1016\/j.bioorg.2026.110309_bb0040","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.drudis.2009.02.011","article-title":"The histamine H3 receptor as a therapeutic target for CNS disorders","volume":"14","author":"Gemkow","year":"2009","journal-title":"Drug Discov. Today"},{"issue":"5911","key":"10.1016\/j.bioorg.2026.110309_bb0045","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/302832a0","article-title":"Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor","volume":"302","author":"Arrang","year":"1983","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110309_bb0050","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/physrev.00043.2007","article-title":"Histamine in the nervous system","volume":"88","author":"Haas","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bioorg.2026.110309_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fnsys.2012.00072","article-title":"Histamine H3 receptor antagonists\/inverse agonists on cognitive and motor processes: relevance to Alzheimer\u2019s disease, ADHD, schizophrenia, and drug abuse","volume":"6","author":"Vohora","year":"2012","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.bioorg.2026.110309_bb0060","first-page":"23","article-title":"Histamine H3 receptor as a potential target for cognitive impairment in epilepsy","volume":"158","author":"Sadek","year":"2016","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110309_bb0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/17512433.2020.1714435","article-title":"Pitolisant for treating patients with narcolepsy","volume":"13","author":"Li","year":"2020","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110309_bb0070","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1476-5381.2011.01286.x","article-title":"The histamine H3 receptor: from discovery to clinical trials with pitolisant","volume":"163","author":"Schwartz","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110309_bb0075","first-page":"378","article-title":"Pitolisant disrupts memory consolidation and hippocampal synaptic plasticity: impaired excitability and long-term potentiation in the CA1 area","volume":"29","author":"Beheshti","year":"2026","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.bioorg.2026.110309_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108888","article-title":"Synthesis of nonimidazole H3 receptor antagonists containing oxazole moiety and their antiseizure activity","volume":"164","author":"Deng","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110309_bb0085","doi-asserted-by":"crossref","DOI":"10.1021\/acsmedchemlett.5c00271","article-title":"Discovery of a novel sp3-rich M1 positive allosteric modulators (PAMs) chemotype via scaffold hopping","author":"Bungard","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110309_bb0090","doi-asserted-by":"crossref","first-page":"118196","DOI":"10.1016\/j.bmc.2025.118196","article-title":"Scaffold hopping and sidechain modification from a flavone scaffold lead to discovery of potent, selective CK2A2 inhibitors with favorable properties for CNS activity","volume":"127","author":"Tucker","year":"2025","journal-title":"Bioorg. Med. Chem."},{"issue":"26","key":"10.1016\/j.bioorg.2026.110309_bb0095","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1021\/jm060642i","article-title":"Structure-brain exposure relationships","volume":"49","author":"Hitchcock","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110309_bb0100","doi-asserted-by":"crossref","unstructured":"Ligneau X, Perrin D, Landais L, Camelot F, Calmels TPG, Berrebi-Bertrand I, Lecomte JM, Parmentier R, Anaclet C, Lin JS, Bertaina-Anglade V, la Rochelle CD, d'Aniello F, Rouleau A, Gbahou F, Arrang JM, Ganellin CR, Stark H, Schunack W, Schwartz JC. BF2.649 [1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist\/antagonist at the human histamine H3 receptor: preclinical pharmacology. J. Pharmacol. Exp. Ther. 2007;320(1):365\u2013375. doi:https:\/\/doi.org\/10.1124\/jpet.106.111039.","DOI":"10.1124\/jpet.106.111039"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110309_bb0105","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1080\/14756366.2020.1774573","article-title":"Design, synthesis, and anticonvulsant effects evaluation of nonimidazole histamine H3 receptor antagonists\/inverse agonists containing triazole moiety","volume":"35","author":"Song","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110309_bb0110","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1007\/s11064-017-2275-z","article-title":"The National Institute of Neurological Disorders and Stroke (NINDS) epilepsy therapy screening program (ETSP)","volume":"42","author":"Kehne","year":"2017","journal-title":"Neurochem. Res."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110309_bb0115","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/hmg\/ddaf056","article-title":"ap4b1\u2212\/\u2212 zebrafish demonstrate morphological and motor abnormalities","volume":"34","author":"Rosengarten","year":"2025","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110309_bb0120","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3390\/molecules25071575","article-title":"Antagonism of histamine H3 receptors alleviates pentylenetetrazole-induced kindling and associated memory deficits by mitigating oxidative stress, central neurotransmitters, and c-Fos protein expression in rats","volume":"25","author":"Amr","year":"2020","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110309_bb0125","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nrd3845","article-title":"Reducing safety-related drug attrition: the use of in vitro pharmacological profiling","volume":"11","author":"Bowes","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110309_bb0130","article-title":"Differentiation of the SH-SY5Y human neuroblastoma cell line","volume":"108","author":"Shipley","year":"2016","journal-title":"J. Vis. Exp."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110309_bb0135","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1073\/pnas.73.7.2424","article-title":"Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor","volume":"73","author":"Greene","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110309_bb0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jps.3030460322","article-title":"A note on a simple apparatus for detecting neurological deficit in rats and mice","volume":"46","author":"Dunham","year":"1957","journal-title":"J. Am. Pharm. Assoc. Am. Pharm. Assoc."},{"issue":"7083","key":"10.1016\/j.bioorg.2026.110309_bb0145","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature04710","article-title":"hERG potassium channels and cardiac arrhythmia","volume":"440","author":"Sanguinetti","year":"2006","journal-title":"Nature"},{"issue":"11\u221212","key":"10.1016\/j.bioorg.2026.110309_bb0150","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1080\/14656566.2025.2523989","article-title":"Efficacy and safety of pitolisant in children above 6 years with narcolepsy","volume":"26","author":"Bertini","year":"2025","journal-title":"Expert Opin. Pharmacother."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110309_bb0155","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1177\/009127000004001004","article-title":"A contract research organization\u2019s response to the new FDA guidances for bioequivalence\/bioavailability studies for orally administered drug products","volume":"40","author":"Kimanani","year":"2000","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110309_bb0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"15","key":"10.1016\/j.bioorg.2026.110309_bb0165","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.3390\/ijms20153724","article-title":"Bioluminescence resonance energy transfer based G protein-activation assay to probe duration of antagonism at the histamine H3 receptor","volume":"20","author":"Mocking","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20133","key":"10.1016\/j.bioorg.2026.110309_bb0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2026.110309_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110309_bb0180","first-page":"193","article-title":"Reporter gene assays for screening GPCR ligands","volume":"552","author":"Hill","year":"2010","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110309_bb0185","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1369\/00221554221083670","article-title":"Histamine H4 receptor expression in triple-negative breast Cancer: an exploratory study","volume":"70","author":"Speisky","year":"2022","journal-title":"J. Histochem. Cytochem."},{"issue":"17\u201318","key":"10.1016\/j.bioorg.2026.110309_bb0190","first-page":"867","article-title":"Histamine H4 receptor antagonists","volume":"14","author":"Lim","year":"2009","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110309_bb0195","first-page":"689","article-title":"Critical review of current animal models of seizures and epilepsy","volume":"52","author":"L\u00f6scher","year":"2011","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110309_bb0200","first-page":"1388","article-title":"Pentylenetetrazole induced seizures in zebrafish","volume":"145","author":"Baraban","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.bioorg.2026.110309_bb0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-62703-640-5_2","article-title":"Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology","volume":"1078","author":"Kovalevich","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"16","key":"10.1016\/j.bioorg.2026.110309_bb0210","article-title":"CCK-8 assay for cell viability assessment","volume":"8","author":"Wang","year":"2018","journal-title":"Bio-Protoc."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2026.110309_bb0215","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110309_bb0220","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bioorg.2026.110309_bb0225","first-page":"87","article-title":"Automated patch clamp analysis of hERG potassium channel blockade","volume":"88","author":"Obergrussberger","year":"2017","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110309_bb0230","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1208\/s12248-023-00837-y","article-title":"Biopharmaceutics risk assessment-connecting critical bioavailability attributes with in vitro, in vivo properties and physiologically based biopharmaceutics modeling to enable generic regulatory submissions","volume":"25","author":"Ahmed","year":"2023","journal-title":"AAPS J."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110309_bb0235","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1124\/dmd.120.000242","article-title":"Use of intravenous infusion study design to simultaneously determine brain penetration and systemic pharmacokinetic parameters in rats","volume":"49","author":"Noh","year":"2021","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110309_bb0240","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr. Comput. Aided Drug Des."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110309_bb0245","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110309_bb0250","first-page":"859","article-title":"Common pitfalls in statistical analysis","volume":"54","author":"Motulsky","year":"2014","journal-title":"J. Clin. Pharmacol."}],"updated-by":[{"DOI":"10.1016\/j.bioorg.2026.110364","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000}},{"DOI":"10.1016\/j.bioorg.2026.110364","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000}}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682600845X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682600845X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:17:07Z","timestamp":1791407827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682600845X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":50,"alternative-id":["S004520682600845X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110309","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel H3R antagonists with potent antiseizure activity and favorable pharmacokinetics via scaffold-hopping from pitolisant to rigid 4-phenylindoles","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110309"}}